On May 20, 2011, the first subject was unblinded in our ongoing US Phase 2 study of MDMA-assisted psychotherapy for PTSD in veterans of war. Now that the research team knows which dose of MDMA the subject …
On March 25, 2011, MAPS Lead Clinical Research Associate Berra Yazar-Klosinski, Ph.D., visited Charleston, SC, to evaluate the progress of our ongoing Phase 2 pilot study of MDMA-assisted psychotherapy …
On January 7 and January 9, 2011, the first experimental sessions took place in our new study of MDMA-assisted psychotherapy for US veterans with chronic, treatment-resistant PTSD. Both patients underwent …
The first two veterans in our newest MDMA-assisted psychotherapy study are now scheduled for their experimental sessions in January. Clinical Investigators Michael Mithoefer, M.D., and Annie Mithoefer, …
We are currently in the recruitment phase of our newest U.S. study of MDMA-assisted psychotherapy for the treatment of posttraumatic stress disorder (PTSD) exclusively with U.S. veterans from the Iraq, …
On September 30, 2010, our clinical team submitted the second protocol amendment for our recently initiated U.S. study of MDMA-assisted psychotherapy for veterans with PTSD to the FDA for review.
MAPS clinical research team visited Charleston, South Carolina to initiate the MAPS-sponsored MDMA/PTSD study with veterans. Clinical Research Associate Berra Yazar-Klosinski and Clinical Program Manager …
Today the second amendment to our study protocol was approved by the IRB. On Sept. 30, we submitted that amendment and our revised investigator’s brochure to the FDA. The amendment returned the NEO …
Amendment 2 makes several changes to the study design and a number of changes to protocol text prior to the start of the study. The protocol has been amended to include the addition of two new outcome …
On Friday, August 27, 2010, an official from the Drug Enforcement Administration (DEA) informed Michael Mithoefer, M.D. that it had approved his Schedule 1 license for MAPS’ MDMA/PTSD study …
On August 9, Michael Mithoefer, M.D., received a Schedule I license from the Drug Enforcement Administration (DEA) to administer MDMA in our Phase 1 study to investigate the effects of MDMA on healthy …
We are now in the process of recruiting subjects for our study of MDMA-assisted psychotherapy for veterans with war-related PTSD. We are mostly seeking veterans from Iraq and Afghanistan but are looking …
